Santanu Boral is a supply chain solution architect and digital transformation strategist for ERP modernization and life sciences.
Imagine a pharmaceutical supply chain confronting a problem that no dashboard or spreadsheet could adequately capture. A warehouse holds enough of a critical drug to satisfy months of projected demand, yet a regional hospital system is experiencing a shortage because the replenishment logic failed to anticipate a sudden demand surge. The inventory exists; the intelligence needed to position it where it is required does not.
Scenarios like this illustrate why the shift toward AI-driven decision frameworks is not simply a technological trend but a fundamental necessity for life sciences supply chains.
Traditional planning models were built for a more predictable world: products have short shelf lives, regulatory requirements vary sharply across geographies and demand can shift overnight due to disease outbreaks, trade rule changes or new clinical guidelines.
According to research from McKinsey & Company, supply chain disruptions now cost companies an average of 45% of one year’s profits over a decade.
The Limitations Of Traditional Inventory Optimization Models
For years, planners relied on two complementary tools: multi-echelon inventory optimization (MEIO), which allocates safety stock across supply chain nodes, and demand forecasting models that projected future consumption from historical data. MEIO helped reduce redundant safety stock across nodes by giving a network-wide view of where inventory was sitting versus where it was needed. But in every supply chain implementation, the outputs of these models fed into human-mediated planning cycles that ran weekly or monthly. By the time a risk surfaced through the system, demand planners had already frozen their monthly plans. The supply chain had already moved.
The limitations became especially clear during Covid-19. Demand patterns became unreliable as the prior MEIO parameters, calibrated on pre-pandemic consumption, were producing safety stock recommendations disconnected from reality. A 2021 Gartner survey found that fewer than half of supply chain leaders rated their organizations as highly capable of scenario-based risk planning—a gap that AI-driven frameworks are specifically designed to close.
The issue with traditional models is not their analytical power but rather their operating assumptions that the key variables (demand, lead time, shelf life) can be modeled independently as these variables interact in complex, nonlinear ways. A lead time spike during a manufacturing disruption simultaneously increases safety stock requirements, accelerates expiry risk and alters demand-sensing corrections.
AI-Driven Framework-Architecture
An AI-driven framework is an integrated architecture with four connected layers that operate in near real time.
1. Data: This layer connects demand signals, supply attributes and shelf life data from separate ERP modules.
2. AI/ML Forecasting: LSTM networks capture nonlinear demand patterns that are connected to a risk-scoring engine that produces not just point forecasts but uncertainty bands. A forecast of 10,000 units is less useful than one that flags a 15% probability of exceeding 13,000 units due to an emerging risk in lead time.
3. MEIO Logic: This ingests those risk signals continuously, updating inventory positioning in real time rather than running on fixed batches.
4. Execution Governance: This layer features automated alerts and exception workflows that, when they surface, require human judgment rather than asking planners to manually process hundreds of SKUs.
The Challenges Of Implementing This Framework
The most consistent challenge is not the AI itself—it is data quality and organizational readiness. In every implementation, the first three months are dominated by data remediation: reconciling master data stored in inconsistent formats across systems.
The organizational dynamics are equally challenging. Planners who have built careers around judgment-based decision-making often experience AI-driven recommendations as a threat rather than a tool.
There is also the question of regulatory compliance. In pharmaceutical supply chains, as AI frameworks need to be designed with these constraints embedded, not bolted on afterward. In practice, this means involving regulatory affairs teams early in the architecture design.
The Strategic Shift: From Efficiency To Resilience
The business case for AI-driven inventory frameworks is typically built on working capital reduction and waste elimination. McKinsey’s research on AI in biopharma operations found that AI-driven supply chain tools deliver a 15% improvement in forecast accuracy alongside inventory reductions of 20-30% across distribution operations. In pharmaceutical companies, the inventory turns are slow and carrying costs are high.
The more important strategic benefit is resilience—the ability to detect risk earlier and respond faster. The organizations that weathered the pandemic supply chain disruptions most effectively were not necessarily the ones with the lowest inventory levels; they were the ones that could sense demand shifts and supply constraints quickly and redirect inventory accordingly.
Blockchain is emerging as a meaningful complement to AI-driven frameworks—not as a replacement for analytical intelligence but as an enabler of the data trust and traceability that these systems require. In regulated supply chains, the ability to trace a specific product lot through every custody transfer strengthens both compliance posture and the quality of the data feeding AI optimization. The combination of AI and blockchain is still early-stage in most pharmaceutical organizations.
For technology leaders to evaluate these frameworks, my recommendation is to sequence-start with data infrastructure. Get clean, real-time data, then build the forecasting and optimization layers next but deploy them initially as decision-support tools rather than automated decision systems. It’s also important to invest in change management since the human system is harder to upgrade.
A Different Kind Of Planning Problem
The inventory paradox I described at the beginning of the article—simultaneous excess and shortage—is not primarily a forecasting failure. It is a coordination failure. The shift from models to frameworks is not about replacing the analytical tools that have served supply chain professionals well. MEIO remains essential for inventory positioning, and machine learning forecasting continues to improve the accuracy of demand prediction. What’s changed is the architecture connecting them.
Organizations that build this capability now will be structurally better positioned to serve patients, manage financial exposure and respond to the next disruption, whatever form it takes.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
